NewsRoom Articles - Page 116 of 202

TuesdayJan 04, 2022 10:42 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Receives Milestone Notice of Allowance for Revolutionary Treatment of Anxiety Disorders

USPTO notice marks important milestone in the expansion of CYBN’s intellectual property portfolio Once issued, patent may have opportunity to cover a broad range of claims Anxiety disorders are one of the most common mental illnesses in the United States Cybin (NEO: CYBN) (NYSE American: CYBN) has taken another step forward in its commitment to progressing Psychedelics to Therapeutics(TM). The biopharmaceutical company has received a notice of allowance from the U.S. Patent and Trademark Office (“USPTO”) in regard to its patent application connected to its investigational deuterated psychedelic tryptamine compound for the potential treatment of anxiety disorders (https://ibn.fm/fpjXm). “The receipt of…

TuesdayJan 04, 2022 9:30 am

Common Applications of Predictive Analytics in the Healthcare Industry

Predictive analytics are a form of technology that make forecasts about specific unknowns in the future. The technology’s use in healthcare offers various benefits, primarily in operational management, administrative tasks and clinical care. The tech is already delivering value in different healthcare settings, including large academic hospitals, healthcare insurance firms and small private physician practices. The technology’s numerous benefits include reductions in cost of healthcare, more consistent patient care and improved patient outcomes. It is expected that the use of predictive analytics in the healthcare industry will become more widespread in the near future. Today, we look at some of…

MondayJan 03, 2022 9:30 am

AI May Soon Replace Mice Models in Brain Cancer Research

Studying tumor growth and treatment is a crucial part of cancer research because it aids in the development of more effective treatments. Despite decades of research, however, drug identification for the treatment of brain cancer is still slow. This is mainly due to the lack of better models for research. This may soon change after Uppsala University researchers used artificial intelligence (“AI”) to develop a new technique to study brain cancer. The technique is based on the transplantation of tumor cells to zebrafish embryos, which are then observed using AI. This technique can partially replace the mouse models that are…

ThursdayDec 30, 2021 9:30 am

Study Finds That Prolonged Sitting Increases Anxiety, Depression

The coronavirus pandemic and the subsequent lockdowns and restrictions imposed as a result to help contain virus spread have impeded a lot of movement. Social distancing has limited social gatherings and people have been allowed to work from home, which has led to increased sedentary behaviors. This sedentary way of life, while reducing work-home commutes and allowing us to stay home more, could be problematic. New research has found that a lack of movement not only impacts our physical health but our mental health as well. The study found that remaining seated for a considerable amount of time was linked…

ThursdayDec 30, 2021 9:00 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Inches Closer to iSTRYM’s Commercial Deployment; Announces Dr. Doron Sagman’s Appointment as CMO; and Avails Recent Life Sciences Virtual Conference Presentation for On-Demand Viewing

MINDCURE just announced receiving its HIPAA certification for iSTRYM, its AI-powered, SaaS platform for psychedelic therapy This marks a key milestone for the company, having already exceeded its target of 10 partner clinics by the end of 2021 It also inches the company closer to the platform’s commercial deployment, set for the second quarter of 2022 This comes just in time, following the appointment of Dr. Doron Sagman as the company’s new CMO MINDCURE’s Life Sciences Virtual Conference Presentation will also be available for on-demand viewing 24/7 for the next 90 days Mind Cure Health (CSE: MCUR) (OTCQX: MCURF) has…

WednesdayDec 29, 2021 9:30 am

Study Finds Factors That May Accurately Forecast Onset of Psychiatric Disorders

New research has found evidence that an extensive range of early onset psychiatric issues like ADHD, bulimia, dyslexia, anxiety and depression are primarily caused by psychological, social and biological factors. The objective of the study, which was conducted by scientists at McGill University, was to better understand the cause of psychiatric disorders. With regard to the factors that may cause these disorders to develop, the psychological factor is associated with temperament, in particular, difficulty controlling emotions and the tendency toward impulsivity. The social factor suggests the crucial role of early childhood abuse or neglect while the biological factor is in…

TuesdayDec 28, 2021 9:30 am

New Research Finds Higher Rates of Multiple Myeloma Precursor Condition in High-Risk Groups

A new study has found higher rates of a precursor condition for myeloma in older individuals who have a close family member with a past or current blood cancer as well as those who are Black. The study, which started in 2019, is the largest screening study to be carried out in the United States. It is being conducted by researchers from the Dana-Farber Cancer Institute, led by Irene Ghobrial. For their study, the researchers recruited more than 7,500 participants — 2,439 of the participates were Black. The objective of the study was to determine the rate of monoclonal gammopathy of…

MondayDec 27, 2021 11:14 am

Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) Recognized as One of the Best Women-Led Workplaces, Participates in the December 16 Life Sciences Virtual Investor Conference

The Great Place to Work organization included MINDCURE in its 2021 list of the Best Workplaces Managed by Women The company was recognized for its employee-oriented perks and programs, which include flexible working hours, monthly team-building events, and a remote work office stipend MINDCURE also participated in the Life Sciences Virtual Investor Conference held on December 16, where executives shared the company’s corporate vision and fielded questions from investors and other attendees Multiple studies have evidenced that women-led companies tend to perform better and are more likely to have more engaged, inspired, and satisfied employees than male-led firms. A Forbes…

MondayDec 27, 2021 9:30 am

Smart Patch Market Expected to Grow to $15 Billion by 2030

A smart patch is a wearable sensor used in the healthcare sector. The patch is usually applied to the skin of a patient using an adhesive and is used to monitor their condition, collecting data on parameters such as blood pressure and heart rate. After collecting the data, the patches share that information to connected electronic devices, including mobiles. Currently, the global market for these sensor-enabled patches is valued at about $8.5 billion. Forecasts show that the market will grow at a compound annual growth rate of 6% between 2022 and 2030 and will be valued at roughly $15.2 billion…

ThursdayDec 23, 2021 9:30 am

FDA Releases Clinical Trial Guidelines Taking into Account CNS Metastases

The Food and Drug Administration recently released new guidance informing sponsors of clinical trials on recommendations to trial designs for systemic oncologic treatments in individuals with central nervous system metastases. According to the new guidelines, researchers must consider leptomeningeal disease, end points, central nervous system assessment, prior therapies and patient population when designing clinical trials. The assessment of tumors is best done through magnetic resonance imaging (“MRI”) with gadolinium contrast. The agency recommends that the involvement of the central nervous system (“CNS”) not be assessed separately from other metastatic illnesses present in other parts of a patient’s body. It adds…